Table 2. Clinical features and pathogens defining the presence of a fungal OI.
Fungi | Clinical Condition |
---|---|
Candida spp. [13, 14, 16, 18] | Severe oropharyngeal candidiasis, esophagitis, candidiasis of trachea and bronchi. Pulmonary candidiasis secondary to tracheobronchial infection is not considered as possible outside some specific neonatal conditions. Invasive candidiasis (end-organ disease, including hematogenous pneumonia). |
Aspergillus spp. [13, 14, 16, 19, 25] | Invasive disease only. |
Pneumocystis jirovecii [13, 14, 16, 19, 25] | Pneumonia or disseminated infections. |
Cryptococcus spp. [13, 14, 16, 23, 26, 27] | Cryptococcosis, extrapulmonary: fungemia, meningitis, osteoarticular, disseminated cutaneous. |
Coccidioides immitis [13, 14, 16, 26] | Coccidioidomycosis, disseminated or extrapulmonary. |
Histoplasma capsultum [13, 14, 16, 26] | Histoplasmosis, disseminated or extrapulmonary. |
Other fungi: [13, 14, 16] Mucormycosis (zygomycosis) (Rhizopus, Mucor and Lichtheimia), Scedosporium/Pseudallescheria boydii, Fusarium, Thalaromyces spp (previously Penicillium marneffei) Geotrichum spp., Saprochaete spp., Magnusiomyces spp. |
Invasive disease. |